Central line placement in patients with and without prophylactic plasma

Area of Science:

• Critical Care Medicine
• Hematology
• Interventional Procedures

Background:

• Central line placement (CLP) is a critical intervention for critically ill patients.
• Coagulation abnormalities, indicated by elevated international normalized ratio (INR), often lead to prophylactic plasma transfusion before CLP.
• Previous data suggest this practice may not be efficacious, yet it persists.

Purpose of the Study:

• To evaluate the efficacy of prophylactic fresh frozen plasma (FFP) transfusion in patients with elevated INR undergoing CLP.
• To assess the impact of preprocedure FFP on bleeding complications during CLP in patients with abnormal coagulation.

Main Methods:

• Retrospective analysis of 287 central line placements over 14 months in an intensive care unit.
• Focus on 100 patients with preprocedure INR > 1.5; 27 received prophylactic FFP.
• Comparison of bleeding events between patients who received FFP and those who did not.

Main Results:

• Only one bleeding event occurred (in a patient with INR 3.9 who received FFP), with no significant difference between FFP and no-FFP groups (0/73 vs 1/27; P = .6).
• The overall incidence of bleeding with CLP was very low (0.3%).
• No demonstrable benefit of prophylactic FFP was observed in reducing bleeding risk.

Conclusions:

• Prophylactic fresh frozen plasma transfusion before central line placement in patients with elevated INR does not appear to reduce bleeding complications.
• The low overall bleeding rate during CLP suggests that routine prophylactic plasma may be unnecessary.
• Further investigation into optimal management of coagulopathic patients undergoing invasive procedures is warranted.